CGTLive®’s Weekly Rewind – October 4, 2024
Review top news and interview highlights from the week ending October 4, 2024.
Data Roundup: September 2024 Features Updates in Ophthalmology Gene Therapy, CAR-T for Lymphoma, and More
Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.
First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas
Estrella noted that the patient had been diagnosed with follicular lymphoma grade 3A with high-risk 3B symptoms.
Around the Helix: Cell and Gene Therapy Company Updates – October 2, 2024
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Anixa Biosciences Seeks Protocol Change to Enable Repeat Dosing in Trial for Ovarian Cancer CER-T
Anixa noted that it had previously obtained clearance of a single-patient investigational new drug application to redose a patient in the trial.
Cilta-cel Boosts Overall Survival in New Early Line Multiple Myeloma Data
The data, from the CARTITUDE-4 clinical trial, compared outcomes to patients treated with standard of care options.
